Effect of desipramine on patients with breathing disorders in RETT syndrome

OBJECTIVE: Rett Syndrome (RTT) is a severe neurodevelopmental condition with breathing disorders, affecting around one in 10,000 female births. Desipramine, a noradrenaline reuptake inhibitor, reduced the number of apneas in Mecp2‐deficient mice, a model of RTT. We planned a phase 2 trial to test it...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancini, Josette, Dubus, Jean‐Christophe, Jouve, Elisabeth, Roux, Jean‐Christophe, Franco, Patricia, Lagrue, Emmanuelle, Castelnau, Pierre, Cances, Claude, Chaix, Yves, Rougeot‐Jung, Christelle, Cornu, Catherine, Desportes, Vincent, Vallée, Louis, Bahi‐Buisson, Nadia, Truillet, Romain, Attolini, Laurence, Villard, Laurent, Blin, Olivier, Micallef, Joëlle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817841/
https://www.ncbi.nlm.nih.gov/pubmed/29468173
http://dx.doi.org/10.1002/acn3.468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817841/
https://www.ncbi.nlm.nih.gov/pubmed/29468173
http://dx.doi.org/10.1002/acn3.468

Ejemplares similares